|
| 36805684 | Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals. | Commun Biol | 2023 |
| 37885158 | Using the power of innate immunoprofiling to understand vaccine design, infection, and immunity. | Hum Vaccin Immunother | 2023 |
| 36999023 | Adenosine deaminase augments SARS-CoV-2 specific cellular and humoral responses in aged mouse models of immunization and challenge. | Front Immunol | 2023 |
| 35202770 | An old problem with new solutions: Strategies to improve vaccine efficacy in the elderly. | Adv Drug Deliv Rev | 2022 |
| 35750334 | Improved Durability to SARS-CoV-2 Vaccine Immunity following Coimmunization with Molecular Adjuvant Adenosine Deaminase-1. | J Immunol | 2022 |
| 35849213 | Aging alters antiviral signaling pathways resulting in functional impairment in innate immunity in response to pattern recognition receptor agonists. | Geroscience | 2022 |
| 36380763 | Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals. | Res Sq | 2022 |
| 35061851 | Pre-vaccination frequency of circulatory Tfh is associated with robust immune response to TV003 dengue vaccine. | PLoS Pathog | 2022 |
| 33280624 | Hospital-acquired <i>Clostridioides difficile</i> infection among patients at an urban safety-net hospital in Philadelphia: Demographics, neighborhood deprivation, and the transferability of national statistics. | Infect Control Hosp Epidemiol | 2021 |
| 33569701 | The impact of immuno-aging on SARS-CoV-2 vaccine development. | Geroscience | 2021 |
| 34298152 | Development and clinical validation of an automated cell cytotoxicity neutralization assay for detecting Clostridioides difficile toxins in clinically relevant stools samples. | Anaerobe | 2021 |
| 34204725 | Peptide Triazole Thiol Irreversibly Inactivates Metastable HIV-1 Env by Accessing Conformational Triggers Intrinsic to Virus-Cell Entry. | Microorganisms | 2021 |
| 32280045 | Adenosine deaminase-1 enhances germinal center formation and functional antibody responses to HIV-1 Envelope DNA and protein vaccines. | Vaccine | 2020 |
| 32057572 | CCR10 expression is required for the adjuvant activity of the mucosal chemokine CCL28 when delivered in the context of an HIV-1 Env DNA vaccine. | Vaccine | 2020 |
| 31942789 | Metastable HIV-1 Surface Protein Env Sensitizes Cell Membranes to Transformation and Poration by Dual-Acting Virucidal Entry Inhibitors. | Biochemistry | 2020 |
| 32837491 | Nonthermal plasma as part of a novel strategy for vaccination. | Plasma Process Polym | 2020 |
| 32973779 | The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development. | Front Immunol | 2020 |
| 29767965 | Bifunctional Chimera That Coordinately Targets Human Immunodeficiency Virus 1 Envelope gp120 and the Host-Cell CCR5 Coreceptor at the Virus-Cell Interface. | J Med Chem | 2018 |
| 30648120 | Defensive Driving: Directing HIV-1 Vaccine-Induced Humoral Immunity to the Mucosa with Chemokine Adjuvants. | J Immunol Res | 2018 |
| 29430306 | A Pilot Study of Immune Activation and Rifampin Absorption in HIV-Infected Patients without Tuberculosis Infection: A Short Report. | Tuberc Res Treat | 2017 |
| 28469517 | A Little Help From the Follicles: Understanding the Germinal Center Response to Human Immunodeficiency Virus 1 Infection and Prophylactic Vaccines. | Clin Med Insights Pathol | 2017 |
| 25943275 | Chemokine-adjuvanted electroporated DNA vaccine induces substantial protection from simian immunodeficiency virus vaginal challenge. | Mucosal Immunol | 2016 |
| 27250739 | Urine colorimetry to detect Low rifampin exposure during tuberculosis therapy: a proof-of-concept study. | BMC Infect Dis | 2016 |
| 24401274 | Neuronal ferritin heavy chain and drug abuse affect HIV-associated cognitive dysfunction. | J Clin Invest | 2014 |
| 25424943 | Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine. | Hum Vaccin Immunother | 2014 |
| 25024365 | An optimized, synthetic DNA vaccine encoding the toxin A and toxin B receptor binding domains of Clostridium difficile induces protective antibody responses in vivo. | Infect Immun | 2014 |
| 22894954 | Non-contact helium-based plasma for delivery of DNA vaccines. Enhancement of humoral and cellular immune responses. | Hum Vaccin Immunother | 2012 |
| 23111167 | DNA-based HIV vaccines do not induce generalized activation in mucosal tissue T cells. | Hum Vaccin Immunother | 2012 |
| 23151454 | Generation of antigen-specific immunity following systemic immunization with DNA vaccine encoding CCL25 chemokine immunoadjuvant. | Hum Vaccin Immunother | 2012 |
| 20952659 | Opioid-induced chemokine expression requires NF-κB activity: the role of PKCζ. | J Leukoc Biol | 2011 |
| 21701683 | Long-term programming of antigen-specific immunity from gene expression signatures in the PBMC of rhesus macaques immunized with an SIV DNA vaccine. | PLoS One | 2011 |
| 21264298 | Novel peptides based on HIV-1 gp120 sequence with homology to chemokines inhibit HIV infection in cell culture. | PLoS One | 2011 |
| 21195801 | High antibody and cellular responses induced to HIV-1 clade C envelope following DNA vaccines delivered by electroporation. | Vaccine | 2011 |
| 19847203 | Plasmids encoding the mucosal chemokines CCL27 and CCL28 are effective adjuvants in eliciting antigen-specific immunity in vivo. | Gene Ther | 2010 |
| 20188250 | Systemic immunization with CCL27/CTACK modulates immune responses at mucosal sites in mice and macaques. | Vaccine | 2010 |
| 19530914 | Plasmid-encoded interleukin-15 receptor alpha enhances specific immune responses induced by a DNA vaccine in vivo. | Hum Gene Ther | 2009 |
| 22573974 | Ultra-fast low concentration detection of Candida pathogens utilizing high resolution micropore chips. | Sensors (Basel) | 2009 |
| 19683780 | High dose of plasmid IL-15 inhibits immune responses in an influenza non-human primates immunogenicity model. | Virology | 2009 |
| 19497647 | Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII. | Vaccine | 2009 |
| 18252865 | DAMGO-induced expression of chemokines and chemokine receptors: the role of TGF-beta1. | J Leukoc Biol | 2008 |
| 19372954 | Treatment interruption as a tool to measure changes in immunologic response to HIV-1. | Curr Opin HIV AIDS | 2008 |
| 18753858 | Sustained suppression of SHIV89.6P replication in macaques by vaccine-induced CD8+ memory T cells. | AIDS | 2008 |
| 18781156 | DNA vaccines: ready for prime time? | Nat Rev Genet | 2008 |
| 18575608 | Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens. | PLoS One | 2008 |
| 17235321 | Enhanced cellular immune responses elicited by an engineered HIV-1 subtype B consensus-based envelope DNA vaccine. | Mol Ther | 2007 |
| 18000037 | Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid. | Proc Natl Acad Sci U S A | 2007 |
| 17584075 | Epitope-driven TB vaccine development: a streamlined approach using immuno-informatics, ELISpot assays, and HLA transgenic mice. | Curr Mol Med | 2007 |
| 17335943 | Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques. | Vaccine | 2007 |
| 16157426 | Mapping of immune responses following wild-type and mutant ABeta42 plasmid or peptide vaccination in different mouse haplotypes and HLA Class II transgenic mice. | Vaccine | 2006 |
| 16763607 | Regression of subcutaneous B16 melanoma tumors after intratumoral delivery of an IL-15-expressing plasmid followed by in vivo electroporation. | Cancer Gene Ther | 2006 |